Yang, Xinyi
Xue, Xiaoqiang
Shi, Ziqiu
Nan, Sha
Lian, Chengying
Ji, Zhigang
Xie, Yi
Liu, Xiaoxuan
Article History
Received: 5 May 2022
Accepted: 22 July 2022
First Online: 9 August 2022
Declarations
:
: The principal investigator’s hospital’s Institutional Review Board (IRB), Peking Union Medical College Hospital, Beijing, China, approved the study verbally. All methods were carried out in accordance with relevant guidelines and regulations of the hospital. This study method had been proven harmless in previous studies. Waiver of documentation of informed consent was permitted because this study conducted no experiments on humans, tissue samples, or data. No patient’s privacy was disclosed in sample videos.
: Not Applicable.
: The authors declare no conflicts of interest.